LAP3 and chronic kidney disease: A comprehensive analysis of serum peptidases activities in patients with chronic kidney disease (CKD) at different disease stages, noted as an alteration in peptidases/proteases activity in the renin–angiotensin system (RAS), is associated with the dysregulation of RAS axes and, consequently, to renal diseases [13].